Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Short-term Investments (2023 - 2025)

Historic Short-term Investments for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $151.3 million.

  • Metagenomi's Short-term Investments fell 3933.5% to $151.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.3 million, marking a year-over-year decrease of 3933.5%. This contributed to the annual value of $220.9 million for FY2024, which is 6918.57% up from last year.
  • Metagenomi's Short-term Investments amounted to $151.3 million in Q3 2025, which was down 3933.5% from $178.1 million recorded in Q2 2025.
  • Over the past 5 years, Metagenomi's Short-term Investments peaked at $249.5 million during Q3 2024, and registered a low of $130.6 million during Q4 2023.
  • For the 3-year period, Metagenomi's Short-term Investments averaged around $198.9 million, with its median value being $208.8 million (2024).
  • Per our database at Business Quant, Metagenomi's Short-term Investments soared by 6918.57% in 2024 and then plummeted by 3933.5% in 2025.
  • Quarter analysis of 3 years shows Metagenomi's Short-term Investments stood at $130.6 million in 2023, then surged by 69.19% to $220.9 million in 2024, then tumbled by 31.5% to $151.3 million in 2025.
  • Its Short-term Investments was $151.3 million in Q3 2025, compared to $178.1 million in Q2 2025 and $196.8 million in Q1 2025.